ADVAGRAF
ADVAGRAF
Approved
DIN Number
02331667
Drug Class
Human
Market Date
Apr 5, 2010
Company
HC
astellas pharma canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02331667
AIG Number0127857006
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L04AD02 TACROLIMUS
Product Specifications
Dosage FormCapsule (Extended Release)
Route of AdministrationOral
AHFS Classification90:28.28.92
Health Canada Classification
ACTIVE INGREDIENTS (1)
TACROLIMUSActive
Strength: 3 MG
Monograph: TACROLIMUS